𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Her-2/neuas Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

✍ Scribed by Wolfgang J. Köstler; Christoph C. Zielinski

Book ID
111559825
Publisher
Springer US
Year
2003
Tongue
English
Weight
115 KB
Volume
81
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum EGFR and serum HER-2/neu are usefu
Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy
✍ Maria Teresa Sandri; Harriet Ann Johansson; Laura Zorzino; Michela Salvatici; Ri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## BACKGROUND. Metronomic chemotherapy has been demonstrated to be of value in patients with advanced breast cancer. No reliable markers of response are available. In breast tumor, HER‐2/__neu__ is a prognostic factor, whereas no definite data exist for EGFR. The aim of the study was t